# Julius Baer Group

> Julius Baer Group is a VC fund backing Financial Services and Banking. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Zürich, Switzerland
- Total investments: 7
- Last investment: Dec 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/julius-baer
- X (Twitter): https://twitter.com/bankjuliusbaer
- Website: http://www.juliusbaer.com
- Facebook: https://www.facebook.com/Bank-Julius-Baer-46285715126

Julius Baer Group is a VC fund in Zürich focused on Financial Services and Banking. Julius Bär Group Ltd. is a Swiss private banking group. The firm concentrates on the needs of individual clients, family offices, and independent asset managers

## Contacts

5 contacts available for Julius Baer Group. Shizune tracks 8 team members at Julius Baer Group. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/julius-baer-group?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Financial Services | 3 | 43% |
| Banking | 2 | 29% |
| Health Care | 2 | 29% |
| Finance | 1 | 14% |
| Lending | 1 | 14% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 29% |
| Series B | 2 | 29% |
| Pre-Seed | 1 | 14% |
| Series C | 1 | 14% |
| Series G | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 29% |
| United Kingdom | 2 | 29% |
| Israel | 1 | 14% |
| Switzerland | 1 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Daniel Borel | Member of the Board of Directors | 0 | — |
| Damien Crommie | Executive Director | 0 | — |
| Dieter Enkelmann | Chief Financial Officer | 0 | — |
| Harry J.F. Bloomfield | Canadian partner | 0 | — |
| Jeremy Cohen | Finance Transformation | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Firenze | Firenze aims to expand financial services by extending investment-backed lending to a wider audience, recognizing its importance in wealth creation and preservation. The founding team aims to democratize Lombard lending, making it accessible to all, while focusing on mass affluent clients. | $938.7K | Pre-Seed | Dec 31, 2024 |  |
| ONE ZERO | FDB is Israel's first digital bank to incorporate artificial intelligence. | $62M | Series B | Feb 05, 2023 |  |
| AMINA Bank AG | SEBA Bank is a cryptocurrency company that provides a seamless, secure, and easy-to-use bridge between digital and traditional assets. Its services allow customers to secure, trade, and manage cryptocurrencies, digital assets, and conventional securities all in one place. It also allows customers and clients to have access to convenient andtransparent investment solutions for their crypto and traditional assets.The company was founded in 2018 and is based in Zug, Zug, Switzerland. | $120.3M | Series C | Jan 12, 2022 |  |
| ONE ZERO | FDB is Israel's first digital bank to incorporate artificial intelligence. | $120M | Series A | Dec 14, 2021 |  |
| dnaNUDGE | dnaNUDGE aims to nudge people towards a better lifestyle based on their DNA. | $60M | Series A | Aug 19, 2021 |  |
| Moderna | Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies insidepatient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck. | $500M | Series G | Feb 01, 2018 |  |
| apps4biz.com | At apps4biz.com™, ease-of-use and affordability are Their passion. They understand that a small business does not have the resources to learn, implement and fully utilize complex systems. apps4biz.com solutions enable you to quickly take advantage of your investment. And, you can easily tailor the apps4biz.com solution to accommodate your businessnow, and as your company grows. | $8M | Series B | Jun 08, 2000 |  |

7 of 7 investments shown.

## Co-investors
- Hebrew University of Jerusalem — VC Fund, 2 deals together
- [Tencent](https://shizune.co/investors/profile/tencent) — VC Fund, 2 deals together
- West Coast Equity Partners — VC Fund, 2 deals together
- [Abu Dhabi Investment Authority](https://shizune.co/investors/profile/abu-dhabi-investment-authority) — VC Fund, 1 deal together
- [Ada Ventures](https://shizune.co/investors/profile/ada-vemtires) — VC Fund, 1 deal together
- [Alameda Research](https://shizune.co/investors/profile/alameda-research) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Julius Baer Group invest in?

Julius Baer Group invests primarily in Financial Services, Banking and Health Care startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Julius Baer Group?

Public channels for Julius Baer Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Julius Baer Group?

The team at Julius Baer Group includes Daniel Borel (Member of the Board of Directors), Damien Crommie (Executive Director) and Dieter Enkelmann (Chief Financial Officer), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co